Article

Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.

Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Blood Purification (impact factor: 2.1). 02/2008; 26(3):284-90. DOI:10.1159/000126925
Source: PubMed

ABSTRACT Bone and mineral disorders may contribute to extraosseous ossifications and cardiovascular disease (CVD) in end-stage renal disease (ESRD) patients. We have investigated the relationship between bone mineral density (BMD) and inflammation, wasting, CVD and mortality in ESRD patients.
BMD (dual energy X-ray absorptiometry) and biochemical, nutritional and inflammatory markers were assessed in 277 incident ESRD patients (GFR 7.1 +/- 0.2 ml/min) who were then followed prospectively for a mean of 27 (range 1-60) months. Carotid plaques were determined in 103 patients.
Patients with carotid plaques, clinical manifestation of CVD and wasting (assessed by subjective global assessment) had significantly lower BMD than their counterparts. Low BMD was associated with high all-cause and cardiovascular mortality. Even after adjustment for several confounders and risk factors, all-cause (HR = 2.1, CI: 1.1-3.9, p = 0.02) and cardiovascular (HR = 2.8, CI: 1.2-6.3, p = 0.02) mortality remained significantly associated with low BMD.
Low BMD is associated with wasting and CVD, and is an independent predictor of all-cause and cardiovascular mortality in ESRD patients.

0 0
 · 
0 Bookmarks
 · 
25 Views

Keywords

277 incident ESRD patients
 
bone mineral density
 
cardiovascular disease
 
cardiovascular mortality
 
carotid plaques
 
clinical manifestation
 
confounders
 
counterparts
 
CVD
 
dual energy X-ray absorptiometry
 
end-stage renal disease
 
ESRD
 
ESRD patients
 
extraosseous ossifications
 
HR
 
low BMD
 
mineral disorders
 
nutritional
 
Patients
 
subjective global assessment